세계의 테라노스틱스 시장 규모는 2023년 37억 달러로 평가되었고, 2024년 43억 달러에서 예측 기간 동안 CAGR 24.0%로 추이할 전망이며, 2029년 말에는 127억 달러에 달할 것으로 예측되고 있습니다.
테라노스틱스 기기의 부문은 2024년 22억 달러로 추정되고, CAGR 9.7%로 추이하며, 2029년 말에는 36억 달러에 이를 것으로 예측됩니다. 또한 테라노스틱스 약의 부문은 2024년 21억 달러에 이르고, CAGR 34.5%로 추이하고 2029년 말에는 91억 달러에 이를 것으로 예측되고 있습니다.
본 보고서에서는 세계의 테라노스틱스 시장을 조사했으며, 시장 개요, 시장 영향 인자 및 시장 기회 분석, 신흥기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
제2장 시장 개요
- 개요
- PESTLE 분석
- Porter's Five Forces 분석
- 연구개발 및 규제 승인
- 의약품 개발 프로세스
- NDA 데이터 리뷰
- 테라노스틱스의 임상시험
- 임상시험에 있어서의 방사선 치료의 순서
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- 종래의 치료법을 대체하는 테라노스틱스
- 창약에서의 테라노스틱스의 용도 증가
- 만성 질환의 만연에 의한 맞춤형 치료 수요 증가
- 새로운 방사선 치료가 테라노스틱스 시장을 견인
- 만성 염증성 질환 증가
- 신흥 국가에서 암의 유행
- 시장 성장 억제요인
- 테라노스틱스의 고비용성
- 시장의 과제
- 나노테라노스틱스 및 바이오의 상호작용
- 방사선 치료의 과제
- 방사선 치료 실패
- 시장 기회
- 심혈관 질환에서 테라노스틱스
제4장 신기술 및 개발
- 테라노스틱스의 AI
- 혁신적인 재료를 사용한 약물전달
- 붕소 중성자 포착 요법(BNCT)
- 루미노겐 응집 유도 발광(AIE)
- 류마티스 관절염(RA)의 테라노스틱스
제5장 시장 세분화 분석
- 세분화의 내역
- 시장 분석 : 제품 유형별
- 테라노스틱스 장비
- 테라노스틱스 약
- 진단약
- 치료제
- 시장 분석 : 용도별
- 암의 병인
- 암 진단
- 암 치료제
- 전립선암
- 신경 내분비 종양
- 갑상선암
- 신경모세포종
- 기타 질환
- 지리적 내역
- 시장 분석 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
제7장 테라노스틱스 시장에서의 지속가능성 : ESG의 관점
- ESG : 서문
- 테라노스틱스 시장에서 주요 ESG 문제
- 직원의 안전
- 방사성폐기물의 처분
- 나노오염
- 테라노스틱스 시장에서 ESG의 현상
- ESG 성능 분석
- BCC로부터의 결론
제8장 부록
- 조사 방법
- 출처
- 약어
- 기업 프로파일
- BAYER AG
- CURIUM PHARMA
- GE HEALTHCARE
- LANTHEUS
- NOVARTIS AG
- SIEMENS HEALTHINEERS AG
- TELIX PHARMACEUTICALS LTD.
- 기타 기업
AJY
The global market for theranostics was valued at $3.7 billion in 2023. The market is expected to grow from $4.3 billion in 2024 to $12.7 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 24.0% from 2024 to 2029.
The global market for theranostics equipment is expected to grow from $2.2 billion in 2024 to $3.6 billion by the end of 2029, at a CAGR of 9.7% from 2024 to 2029.
The global market for theranostics agents is expected to grow from $2.1 billion in 2024 to $9.1 billion by the end of 2029, at a CAGR of 34.5% from 2024 to 2029.
Report Scope:
This report provides a comprehensive summary of the theranostics market. It profiles all the major companies present in the market, including revenues, product portfolios and recent activities. It examines the competitive landscape, market trends and market dynamics such as drivers, restraints and opportunities. The report provides historic, current and projected market value. By product type, the market is segmented into theranostics equipment and theranostics agents. Theranostics equipment includes PET/CT, SPECT/CT and others; the theranostics agents studied are diagnostics and therapeutics agents. The regions considered are North America, Europe, Asia-Pacific, and the Rest of the World. The top countries in each region are also profiled. The market is also segmented by application.
Report Includes:
45 data tables and 37 additional tables
- An overview of the global markets for theranostics
- Analysis of trends in the global market for theranostics, with revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects specific to theranostics, along with a market share analysis by product type, application, and region
- Assessment of current applications for theranostics and emerging applications such as macular degeneration, gynecology, cutaneous hypersensitivity and cardio-respiratory medicines
- Identification of technological and industry trends in each market segment, as well as the manufacturers of products used in theranostics, reagents and instrumentation for theranostics research, as well as suppliers of theranostics-related services
- Assessment of global R&D activity related to theranostics, resulting in the issuance of patents
- A discussion of ESG challenges and ESG practices in the industry
- Analysis of the key companies' market shares, proprietary technologies and strategic alliances
- Profiles of the leading players, including GE Healthcare, Siemens Healthineers AG, Novartis, Lantheus and Telix Pharmaceuticals Ltd.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- PESTLE Analysis
- Political
- Economic
- Social
- Technological
- Legal
- Environmental
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential of New Entrants
- Competition in the Industry
- Threat of Substitutes
- R&D and Regulatory Approval
- The Drug Development Process
- Drug Discovery
- Preclinical Development
- Clinical Trials
- The New Drug Application Review
- NDA Data Review
- Clinical Trials for Theranostics
- Steps Followed for Radiotherapeutics in Clinical Trials
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Theranostics Replacing Conventional Treatment
- Increased Application of Theranostics in Drug Discovery
- Prevalence of Chronic Diseases is Increasing the Demand for Personalized Treatment
- New Radiotheranostics Driving the Theranostics Market
- Rise in Chronic Inflammatory Diseases
- Cancer Epidemics in Developing Countries
- Market Restraints
- High Cost of Theranostics
- Market Challenges
- Nanotheranostics-Bio Interactions
- Challenges of Radiotheranostics
- Failure of Radiotherapeutics
- Market Opportunities
- Theranostics in Cardiovascular Diseases
Chapter 4 Emerging Technologies and Developments
- Artificial Intelligence in Theranostics
- Drug Delivery Using Innovative Material
- Boron Neutron Capture Therapy (BNCT)
- Luminogen Aggregation-Induced Emission (AIE)
- Theranostics in Rheumatoid Arthritis (RA)
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Product Type
- Theranostics Equipment
- Theranostics Agents
- Diagnostics Theranostics Agents
- Therapeutics Theranostics Agents
- Market Analysis, by Application
- Etiology of Cancer
- Cancer Diagnosis
- Cancer Therapeutics
- Prostate Cancer
- Neuroendocrine Tumors
- Thyroid Cancer
- Neuroblastoma
- Other Diseases
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Strategic Analysis
- Clinical Trials Analysis
Chapter 7 Sustainability in Theranostics Market: An ESG Perspective
- Introduction to ESG
- Key ESG Issues in the Theranostics Market
- Safety of Personnel
- Disposal of Radioactive Waste
- Nanopollution
- Current Status of ESG in the Theranostics Market
- ESG Performance Analysis
- Concluding Remark from BCC Research
Chapter 8 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- BAYER AG
- CURIUM PHARMA
- GE HEALTHCARE
- LANTHEUS
- NOVARTIS AG
- SIEMENS HEALTHINEERS AG
- TELIX PHARMACEUTICALS LTD.
- Other Companies
